Chapter 25: Problem 12
Suggest an explanation for the fact that the amount of glycogen in type I glycogen-storage disease (von Gierke disease) is increased.
Short Answer
Expert verified
Von Gierke disease increases glycogen due to glucose-6-phosphatase deficiency, causing glucose-6-phosphate accumulation and glycogen synthesis.
Step by step solution
01
Understanding Glycogen Storage Disease Type I
Type I glycogen-storage disease, also known as von Gierke disease, is a genetic disorder caused by a deficiency of the enzyme glucose-6-phosphatase. This enzyme is crucial for the final step of gluconeogenesis and glycogenolysis, converting glucose-6-phosphate into free glucose, which is then released into the bloodstream.
02
Role of Glucose-6-Phosphatase
In a healthy individual, glucose-6-phosphatase breaks down glucose-6-phosphate into glucose. However, in individuals with von Gierke disease, this enzyme is deficient or non-functional, causing glucose-6-phosphate to accumulate in the liver and kidney cells, as it cannot be converted into glucose for circulation.
03
Glycogen Accumulation
The accumulation of glucose-6-phosphate in cells occurs because it cannot progress to the next step in the metabolic pathway. This buildup results in an increased synthesis of glycogen, as excess glucose-6-phosphate drives the formation of glycogen via the glycogen synthase pathway.
04
Conclusion: Increased Glycogen Storage
Due to the continuous synthesis and lack of effective breakdown of glycogen caused by the enzyme deficiency, individuals with von Gierke disease exhibit increased glycogen storage in their liver and kidneys, leading to hepatomegaly and nephromegaly, common symptoms of the disease.
Unlock Step-by-Step Solutions & Ace Your Exams!
-
Full Textbook Solutions
Get detailed explanations and key concepts
-
Unlimited Al creation
Al flashcards, explanations, exams and more...
-
Ads-free access
To over 500 millions flashcards
-
Money-back guarantee
We refund you if you fail your exam.
Over 30 million students worldwide already upgrade their learning with Vaia!
Key Concepts
These are the key concepts you need to understand to accurately answer the question.
Understanding Glucose-6-Phosphatase Deficiency
Glucose-6-phosphatase deficiency is the primary cause of von Gierke disease, a genetic condition that affects the body's ability to manage glycogen stores efficiently. This deficiency leads to a disruption in glucose production, specifically hindering the conversion of glucose-6-phosphate into free glucose. As a result, glucose cannot be released into the bloodstream.
In a healthy body, this enzyme is a vital part of gluconeogenesis and glycogenolysis, which are processes that help regulate blood sugar levels by releasing glucose from stored glycogen. Without glucose-6-phosphatase, these pathways become interrupted, causing glucose-6-phosphate to accumulate inside cells, specifically in the liver and kidneys.
In a healthy body, this enzyme is a vital part of gluconeogenesis and glycogenolysis, which are processes that help regulate blood sugar levels by releasing glucose from stored glycogen. Without glucose-6-phosphatase, these pathways become interrupted, causing glucose-6-phosphate to accumulate inside cells, specifically in the liver and kidneys.
Exploring Gluconeogenesis
Gluconeogenesis is a metabolic pathway that generates glucose from non-carbohydrate substrates. It usually kicks in when your body runs low on glucose.
In von Gierke disease, gluconeogenesis is impeded due to the deficiency of glucose-6-phosphatase. This enzyme typically facilitates the final step where glucose-6-phosphate is converted into free glucose, ready to be released into the bloodstream.
Without functioning gluconeogenesis, other pathways, like glycogen breakdown, cannot compensate for the glucose shortage, leading to low blood sugar levels, or hypoglycemia, during fasting or between meals.
In von Gierke disease, gluconeogenesis is impeded due to the deficiency of glucose-6-phosphatase. This enzyme typically facilitates the final step where glucose-6-phosphate is converted into free glucose, ready to be released into the bloodstream.
Without functioning gluconeogenesis, other pathways, like glycogen breakdown, cannot compensate for the glucose shortage, leading to low blood sugar levels, or hypoglycemia, during fasting or between meals.
Importance of Glycogen Synthesis
Glycogen synthesis is the process through which excess glucose-6-phosphate is converted into glycogen for storage. Glycogen serves as a quick-release form of glucose, crucial for body functions, especially during fasting periods.
In von Gierke disease, because glucose-6-phosphate cannot be transformed into glucose, it pushes the body towards the glycogen synthesis pathway more than usual. This process is facilitated by the enzyme glycogen synthase. The increased activity due to accumulated glucose-6-phosphate results in excessive glycogen storage, mainly in the liver and kidneys.
This excess storage can cause organ enlargement, specifically the liver and kidneys, due to the abnormal glycogen buildup.
In von Gierke disease, because glucose-6-phosphate cannot be transformed into glucose, it pushes the body towards the glycogen synthesis pathway more than usual. This process is facilitated by the enzyme glycogen synthase. The increased activity due to accumulated glucose-6-phosphate results in excessive glycogen storage, mainly in the liver and kidneys.
This excess storage can cause organ enlargement, specifically the liver and kidneys, due to the abnormal glycogen buildup.
Von Gierke Disease Symptoms
Von Gierke disease presents with several symptoms due to the metabolic imbalances caused by glucose-6-phosphatase deficiency.
Some common symptoms include:
Some common symptoms include:
- Hypoglycemia: Low blood sugar levels, especially between meals or during fasting.
- Hepatomegaly: Enlargement of the liver due to excessive glycogen storage.
- Nephromegaly: Kidney enlargement also resulting from glycogen buildup.
- Growth retardation: Slowed growth in children due to poor energy supply.
- Lactic acidosis: Excess lactic acid in the body due to metabolic pathway disruptions.